Chenguang Biotech: Net profit in the first half of 2025 increased by 115.33% year-on-year.

Morning Light Biology Announcement: In the first half of 2025, the company achieved operating income of 3.658 billion yuan, an increase of 4.77% year-on-year; net profit attributable to shareholders of the listed company was 215 million yuan, an increase of 115.33% year-on-year. During the reporting period, most plant extract product prices fell year-on-year due to the decrease in raw material costs, but benefited from sales growth, revenue from natural pigments/spices/nutritional and medicinal plant extract products increased by 9.47%, achieving a year-on-year increase in gross profit of 32%, with significantly improved profitability and a year-on-year increase in gross profit margin by 3.43%.